Skip to content
Politically.com Search all
Menu

2026 · 2nd Quarter (Apr 1 - June 30)

ASSOCIATION FOR ACCESSIBLE MEDICINES

Filed by THE GIBSON GROUP, LLC.

Open official filing
Source: Lobbying Disclosure APIRecently refreshed. 2026-08-03 06:26:15 UTC.

Source-reported fields

Filing overview

Type
2nd Quarter - Report
Posted
Jul 10, 2026
Income
$70,000.00
Expenses
Not reported
Filing UUID
e0921ebc-9c23-4d56-b410-7b4c56d18a02
Termination date
Not reported

Literal source text

Lobbying issues and bill citations

HCR · Health Issues

Drug competition issues Monitor drug supply chain issues

LBR · Labor Issues/Antitrust/Workplace

Drug competition issues

CPT · Copyright/Patent/Trademark

Monitor S. 1096 - patent settlements Issues relating to review of pharmaceutical patents in inter partes reviews Issues relating to the Patent Trial and Appeal Board Patent thickets - S. 1041 Monitor S. 1040 - product hopping Skinny labeling issues Monitor issues relating to the Patent Eligibility Restoration Act Monitor issues relating to the PREVAIL Act

Literal federal measure citations: S. 1096, S. 1041, S. 1040

TRD · Trade (domestic/foreign)

Monitor issues related to trade agreeements

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.